Navigation Links
Regenerative Medicine Company BioParadox adds Healthcare and Medical Device Expert, Michael Kleine, to its Board of Directors
Date:12/12/2011

MENLO PARK, Calif., Dec. 12, 2011 /PRNewswire/ -- BioParadox, Inc., a regenerative medicine company pioneering point-of-care biologic treatments for cardiovascular disease, today announced that Michael Kleine, President & Chief Executive Officer of EndoGastric Solutions, Inc. has joined its Board of Directors.

"Mr. Kleine's impressive leadership experience in the field will accelerate the commercialization of our novel biologic cardiovascular therapies.  We are delighted to have him as part of the team," said Allan Mishra, MD, Founder of BioParadox.   

Mr. Kleine has more than 25 years of experience in the medical device and healthcare industries. He has successfully managed several global biomedical companies focused on the market advancement of numerous leading-edge products through commercialization strategies and operational excellence.

Previously, Mr. Kleine has served as President & Chief Executive Officer of Biosensors. After major restructuring of the Company, he achieved record revenue and market share gains by focusing on markets in Asia/Pacific, China and Europe. Under his leadership, the market cap of Biosensors grew from $187 million to $662 million. Prior to that, he served as President and Chief Executive Officer of Microvention Inc., a leading developer, manufacturer and marketer of minimally invasive products for treatment of cerebral and peripheral vascular disease.  During his tenure at Microvention, Mr. Kleine successfully grew the company until it was acquired by Terumo Corporation (Japan). 

Mr. Kleine also served as Chief Executive Officer of Thermo Cardiosystems Inc., an $80 million manufacturer and distributor of left ventricular assist systems, incision and blood coagulation devices, until its acquisition by Thoratec. He was also the former President and Chief Executive Officer of Sorin Biomedical Inc., a $54 million manufacturer and distributor of cardiopulmonary equipment that successfully merged with Cobe, Inc. and President of Bird Medical Technologies, a $64 million manufacturer and distributor of ventilators and disposable respirator and infection control products.

About BioParadox

BioParadox is innovating the use of Platelet Cell Therapy (PCT) for the treatment of cardiovascular disease. The company's first products, VitaKine® and RevaTen® are proprietary formulations that have been shown to enhance cardiovascular function. They are produced exclusively by BioParadox.

For more information, please visit: BioParadox.com or e-mail: info@bioparadox.com

 

 


'/>"/>
SOURCE BioParadox
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
2. Hard To Treat Diseases (HTDS.PK) Stem Cells and Regenerative Medicine
3. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
4. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
5. The Impact of Very Small Embryonic-Like Stem Cells in Regenerative Medicine is Highlighted by Five Posters and Two Oral Presentations at the 2009 American Society of Hematology Annual Meeting
6. Speakers to Focus on Translating Regenerative Medicine Science
7. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
8. Audax Medical, Inc. Receives Therapeutic Discovery Grant for Development of Regenerative Bone Material
9. Reportlinker Adds Regenerative Medicine Markets
10. BioLife Solutions Increases 2011 Financial, Scientific, Technical Support of the Regenerative Medicine Industry
11. Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 Today Stock-Callers.com ... stocks, which are: Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: ... (NASDAQ: SSH ). These companies are part of ... gains on Thursday, March 23 rd , 2017, with the ... shares of health care companies in the S&P 500 were ...
(Date:3/24/2017)... 23, 2017  HealthMine surveys with 9,250 insured consumers ... health plan members want help from their plans in ... in their health, 2) help closing gaps in care, ... health and 5) relevant, real-time guidance. Meeting these needs ... costs. A Reason to Stay ...
(Date:3/24/2017)... -- The Board of Directors of Nordic Nanovector ... including the complete 2016 Annual Accounts with notes. The report ... website in the section Investor Relations/Reports and presentations/Annual Reports. ... For further ... Financial Officer Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com ...
Breaking Medicine Technology:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Center, Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, proudly ... Delgado, June 9--24, 2017. This sacred and spiritual journey during the Summer ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will ... The majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A ... minister and college Bible teacher residing in North Carolina with his wife, Anna Marie. ... blessed them with six grandchildren. David is also the author of “Shadow and Substance.” ...
(Date:3/23/2017)... ... , ... A recent report from the National Council on Teacher Quality (NCTQ) ... suggests, based on a review of GPA and SAT/ACT requirements at 221 institutions in ... It argues that this higher bar should be set by states, by the Council ...
Breaking Medicine News(10 mins):